Clinical Trial Update: Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication [Phase 4]

View source ↗

Summary

A Phase 4 trial updating on the use of two second-generation trabecular micro-bypass stents in glaucoma patients on one hypotensive medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Second-generation trabecular micro-bypass stents (trabecular micro-bypass stents)

Snippet

Sponsor: Glaukos Corporation | Conditions: Open Angle Glaucoma | Phase 4 | Status: COMPLETED